Friday, April 18, 2025
Home Tags Innv

Tag: innv

Steven Boyd, Armistice Capital, Biotech Stock Review
Biotech News

Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.

Editor / Curator -
biotech stock review
Biotech News

Innovus (INNV) Gains 75% in Past Week.

Editor / Curator -
Biotech News

Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase...

Editor / Curator -
Biotech News

Innovus (INNV) New E-Commerce Store on Track for $3 million in...

Editor / Curator -
DIABASENS
All News

Diabasens® to Launch in Europe. Innovus (INNV).

Editor / Curator -
Biotech News

Innovus (INNV) in Silicon Review Interview.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Transcript.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

Editor / Curator -
biotech stock review, innovus
All News

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Editor / Curator -
biotech stock review, zestra
Biotech News

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for...

Editor / Curator -
12Page 1 of 2

Latest article

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...

Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

2025 Watch List Editor / Curator -
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.